BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37322534)

  • 1. Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
    de Waard J; Bhattacharya A; de Boer MT; van Hemel BM; Esajas MD; Vermeulen KM; de Bock GH; Schuuring E; Wisman GBA
    Clin Epigenetics; 2023 Jun; 15(1):103. PubMed ID: 37322534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
    Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Meijer CJLM; Melchers WJG; Bekkers RL; Molijn AC; Quint WG; van Kemenade FJ; Berkhof J; Heideman DAM
    Int J Cancer; 2022 Feb; 150(3):440-449. PubMed ID: 34558659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
    Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
    Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
    Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
    Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women.
    Boers A; Bosgraaf RP; van Leeuwen RW; Schuuring E; Heideman DA; Massuger LF; Verhoef VM; Bulten J; Melchers WJ; van der Zee AG; Bekkers RL; Wisman GB
    Br J Cancer; 2014 Sep; 111(6):1095-101. PubMed ID: 25032730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Adcock R; Nedjai B; Lorincz AT; Scibior-Bentkowska D; Banwait R; Torrez-Martinez N; Robertson M; Cuzick J; Wheeler CM;
    Int J Cancer; 2022 Oct; 151(7):993-1004. PubMed ID: 35477862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
    Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
    Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
    Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population.
    Li N; Hu Y; Zhang X; Liu Y; He Y; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2021 Apr; 148(7):1768-1777. PubMed ID: 33300604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
    Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
    Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.
    van den Helder R; Steenbergen RDM; van Splunter AP; Mom CH; Tjiong MY; Martin I; Rosier-van Dunné FMF; van der Avoort IAM; Bleeker MCG; van Trommel NE
    Clin Cancer Res; 2022 May; 28(10):2061-2068. PubMed ID: 35266975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis.
    Salta S; Lobo J; Magalhães B; Henrique R; Jerónimo C
    Clin Epigenetics; 2023 Aug; 15(1):125. PubMed ID: 37533074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
    Vink FJ; Lissenberg-Witte BI; Meijer CJLM; Berkhof J; van Kemenade FJ; Siebers AG; Steenbergen RDM; Bleeker MCG; Heideman DAM
    Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.
    Verlaat W; Snoek BC; Heideman DAM; Wilting SM; Snijders PJF; Novianti PW; van Splunter AP; Peeters CFW; van Trommel NE; Massuger LFAG; Bekkers RLM; Melchers WJG; van Kemenade FJ; Berkhof J; van de Wiel MA; Meijer CJLM; Steenbergen RDM
    Clin Cancer Res; 2018 Jul; 24(14):3456-3464. PubMed ID: 29632006
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA methylation for cervical cancer screening: a training set in China.
    Kong L; Wang L; Wang Z; Xiao X; You Y; Wu H; Wu M; Liu P; Li L
    Clin Epigenetics; 2020 Jun; 12(1):91. PubMed ID: 32576279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.